229 related articles for article (PubMed ID: 30371585)
41. Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.
Mahajan S; Shaha A; Grewal RK
Clin Nucl Med; 2018 Feb; 43(2):136-138. PubMed ID: 29261627
[TBL] [Abstract][Full Text] [Related]
42. The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience.
Das S; Pineda G; Goff L; Sobel R; Berlin J; Fisher G
Cancer Imaging; 2018 Dec; 18(1):47. PubMed ID: 30522522
[TBL] [Abstract][Full Text] [Related]
43. Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa.
Lawal IO; Ololade KO; Lengana T; Reyneke F; Ankrah AO; Ebenhan T; Vorster M; Sathekge MM
Hell J Nucl Med; 2017; 20(2):128-133. PubMed ID: 28697189
[TBL] [Abstract][Full Text] [Related]
44. [Detection of neuroendocrine tumors by positron emission tomography-computed tomography with 68Ga-DOTATATE: report of one case].
Amaral H; Pruzzo R; Redondo F; Gil MC; Pizarro A; de la Fuente H; Butte JM; Coudeu TM
Rev Med Chil; 2009 Apr; 137(4):537-41. PubMed ID: 19623420
[TBL] [Abstract][Full Text] [Related]
45. Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.
Papadakis GZ; Millo C; Sadowski SM; Karantanas AH; Bagci U; Patronas NJ
Clin Nucl Med; 2017 Mar; 42(3):209-210. PubMed ID: 28072620
[TBL] [Abstract][Full Text] [Related]
46. Cardiac neuroendocrine tumour metastases: case reports and review of the literature.
Bonsen LR; Aalbersberg EA; Tesselaar M; Stokkel MP
Nucl Med Commun; 2016 May; 37(5):461-5. PubMed ID: 26671851
[TBL] [Abstract][Full Text] [Related]
47. False-Positive Uptake in Splenic Hemangioma on 68 Ga-DOTATATE PET/CT.
Zhu B; Yoon E; Mahajan S; Kranz AO
Clin Nucl Med; 2023 Jun; 48(6):518-519. PubMed ID: 37075248
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT.
Kunz WG; Eschbach RS; Stahl R; Kazmierczak PM; Bartenstein P; Rominger A; Auernhammer CJ; Spitzweg C; Ricke J; Cyran CC
Cancer Imaging; 2018 Sep; 18(1):34. PubMed ID: 30236163
[TBL] [Abstract][Full Text] [Related]
49. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
[TBL] [Abstract][Full Text] [Related]
50. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J
J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441
[TBL] [Abstract][Full Text] [Related]
51. The value of
Liu KY; Goldrich DY; Ninan SJ; Filimonov A; Lam H; Govindaraj S; Iloreta AM
Head Neck; 2021 Jun; 43(6):E30-E40. PubMed ID: 33786927
[TBL] [Abstract][Full Text] [Related]
52. Intrapancreatic Accessory Spleen Mimicking Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT.
Bhure U; Metzger J; Keller FA; Zander A; Lago MP; Herring K; Strobel K
Clin Nucl Med; 2015 Sep; 40(9):744-5. PubMed ID: 26053721
[TBL] [Abstract][Full Text] [Related]
53. Current Concepts in
Bodei L; Ambrosini V; Herrmann K; Modlin I
J Nucl Med; 2017 Nov; 58(11):1718-1726. PubMed ID: 28818983
[No Abstract] [Full Text] [Related]
54. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
[TBL] [Abstract][Full Text] [Related]
55. Polyostotic Fibrous Dysplasia in McCune-Albright Syndrome Demonstrated on 68Ga-DOTATATE PET/CT.
Hennessy G; Shetty D; Loh H; Bui C; Le K; Mansberg R
Clin Nucl Med; 2016 Dec; 41(12):982-985. PubMed ID: 27740949
[TBL] [Abstract][Full Text] [Related]
56. Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach.
Werner RA; Weich A; Higuchi T; Schmid JS; Schirbel A; Lassmann M; Wild V; Rudelius M; Kudlich T; Herrmann K; Scheurlen M; Buck AK; Kropf S; Wester HJ; Lapa C
Theranostics; 2017; 7(6):1489-1498. PubMed ID: 28529632
[TBL] [Abstract][Full Text] [Related]
57. Most of the Intended Management Changes After
Calais J; Czernin J; Eiber M; Fendler WP; Gartmann J; Heaney AP; Hendifar AE; Pisegna JR; Hecht JR; Wolin EM; Slavik R; Gupta P; Quon A; Schiepers C; Allen-Auerbach MS; Herrmann K
J Nucl Med; 2017 Nov; 58(11):1793-1796. PubMed ID: 28473600
[TBL] [Abstract][Full Text] [Related]
58. Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
Haug AR; Cindea-Drimus R; Auernhammer CJ; Reincke M; Beuschlein F; Wängler B; Uebleis C; Schmidt GP; Spitzweg C; Bartenstein P; Hacker M
Radiology; 2014 Feb; 270(2):517-25. PubMed ID: 24056402
[TBL] [Abstract][Full Text] [Related]
59. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
Abdulrezzak U; Kurt YK; Kula M; Tutus A
Nucl Med Commun; 2016 Aug; 37(8):874-81. PubMed ID: 27096719
[TBL] [Abstract][Full Text] [Related]
60. 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor.
Kömek H; Gündoğan C; Can C
Clin Nucl Med; 2021 May; 46(5):e290-e292. PubMed ID: 33351508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
